PLUS1
34.9899
-0.1001 (-0.29%)
-0.1001 (-0.29%)
Upgrade to Real-Time
Afterhours (Closed)
Low
1.11
High
117.54
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cassava Sciences Inc | SAVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.1001 | -0.29% | 34.9899 | 00:00:08 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 34.65 | 33.68 | 35.33 | 34.85 | 35.09 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 31.88 | 37.00 | 5.12 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,912 | 1,029,148 | $ 34.70 | $ 35,716,264 | 2,693,419 | 1.11 - 117.54 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:49 | 1 | $ 34.99 | USD |
Cassava Sciences Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.22B | 34.95M | 33.13M | $ - | $ - | -0.27 | -51.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Cassava Sciences News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/31/2021 | 16:26 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) |
| 3/23/2021 | 17:06 | Edgar (US Regulatory) | Annual Report (10-k) |
| 3/23/2021 | 09:28 | Seeking Alpha | Cassava Sciences EPS misses by $0.04 |
| 3/23/2021 | 08:55 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 3/23/2021 | 08:30 | GlobeNewswire Inc. | Cassava Sciences Announces Full-year 2020 Financial Results.. |
| 3/19/2021 | 20:34 | TipRanks | Cassava: A Promising Yet Risky Alzheimer’s Pure Play |
| 3/18/2021 | 16:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SAVA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 41.69 | 42.27 | 33.68 | 36.32 | 1,355,845 | -6.70 | -16.07% |
| 1 Month | 57.0263 | 59.89 | 33.68 | 45.52 | 1,463,162 | -22.04 | -38.64% |
| 3 Months | 11.75 | 117.54 | 11.71 | 55.96 | 6,924,471 | 23.24 | 197.79% |
| 6 Months | 10.98 | 117.54 | 6.70 | 40.14 | 4,845,397 | 24.01 | 218.67% |
| 1 Year | 5.51 | 117.54 | 1.11 | 21.71 | 5,234,096 | 29.48 | 535.03% |
| 3 Years | 1.21 | 117.54 | 1.00 | 18.14 | 3,294,819 | 33.78 | 2,791.73% |
| 5 Years | 1.21 | 117.54 | 1.00 | 18.14 | 3,294,819 | 33.78 | 2,791.73% |
Cassava Sciences Description
| Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. It is also developing an experimental biomarker diagnostic PTI-125 to detect Alzheimer's disease with the help of a blood test. |
